The HealthCare Institute of New Jersey (HINJ) will convene researchers, business leaders and the healthcare community to explore the latest policies, innovation and collaborations driving the future of pharma and medtech at its 2nd Annual Life Sciences Summit next week.
Pulse 2026: Saving Lives Globally; Driving Our Economy Locally is a free event that will be held from 8 a.m. to 12 noon on Friday, March 13, at Middlesex College in Edison. New Jersey’s research-based biopharmaceutical and medical technology community, state policymakers, patient advocates, workforce partners, and academic leaders will be participating.
NJBIA President & CEO Michele Siekerka will moderate a discussion on “Growing the Innovation Economy: Federal and State Policy Impacts” that will explore the federal and state actions that are shaping investment, research, manufacturing, and the state’s competitiveness in the life sciences and technology sectors.
Experts for this panel discussion on growing innovation are:
- Ali A. Houshmand, Ph.D., President, Rowan University
- Dan Leonard, Executive Director, We Work For Health (WWFH) a coalition of business leaders, labor unions, patient advocates, and biopharmaceutical companies that promotes policies to support life science innovation
- Chris Paladino, President, New Brunswick Development Corporation (DEVCO)
- William F. Tate, Ph.D., President, Rutgers University
- Cyndie Williams, Executive Director, Carpenter Contractor Trust
For more information and to register to attend Pulse 2026, go here.
